Director Saintil Merline of Symbotic Inc. (NASDAQ: SYM) disclosed the sale of 3,414 shares of Class A common stock on March 11, 2026, in a Form 4 filing with the Securities and Exchange Commission. The transactions, executed under a pre-arranged trading plan, generated approximately $173,483 in gross proceeds.
The sales were reported as two separate trades. The larger tranche consisted of 3,114 shares sold at a weighted average price of $50.7575, with individual execution prices reported between $50.17 and $51.16. The smaller tranche covered 300 shares sold at a weighted average price of $51.4167, with trade prices ranging from $51.18 to $51.65.
After completing the reported transactions, Merline is listed as directly holding 75,344 shares of Symbotic common stock.
At the time of the disclosure the stock was trading at $49.43, a level below the weighted prices at which the sales occurred. The filing notes the trades were made under a pre-arranged plan, indicating the transactions were scheduled prior to the execution date.
Recent operational and market context
Symbotic’s latest quarterly results for the first quarter of fiscal 2026 presented a mixed picture. The company reported earnings per share of $0.02, missing the consensus forecast of $0.08 by 75%. Revenue, however, came in ahead of expectations at $630 million versus an anticipated $622.58 million.
Analyst reactions included a KeyBanc upgrade of the stock rating from Sector Weight to Overweight, with the firm citing positive deployment outlooks gleaned from meetings with Symbotic executives. DA Davidson adjusted its price target upward to $57 from $53 but retained a Neutral rating, pointing to expectations for accelerated organic sales growth through fiscal year 2027.
Market-performance context included data from InvestingPro showing a 128% return for the stock over the past year. That same data set flagged SYM as remaining undervalued on a Fair Value analysis basis and listed it among opportunities identified as most undervalued stocks.
What this means going forward
The Form 4 filing documents a planned insider sale executed at prices above the contemporaneous market quote. The company’s mixed quarterly metrics and the subsequent adjustments and commentary from analysts provide a snapshot of investor and sell-side reassessment during this period.